有机化学人才网 | 最新人才 | 最新职位 | 技术交易 | 药物合成 |
   
全站搜索: |
  您当前位置:网站首页 >> 药物合成路线图解
 

药物详细合成路线

Name Quinagolide hydrochloride;SDZ-205502;CV-205502;Norprolac
Chemical Name (±)-N,N-Diethyl-N-[(3alpha,4aalpha,10abeta)-6-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-3-yl]sulfamide hydrochloride
CAS 94424-50-7
Related CAS 87056-78-8 (free base)
Formula C20H34ClN3O3S
Structure
Formula Weight 432.02928
Stage 上市-1994
Company Novartis (Originator)
Activity/Mechanism Contraceptives, Disorders of Sexual Function and Reproduction, Treatment of, ENDOCRINE DRUGS, Male Contraceptives, Pituitary Disorder Therapy, Treatment of Acromegaly, Treatment of Growth Hormone Secretion Disorders, Treatment of Hyperprolactinemia, Dopamine D2 Agonists, Prolactin Secretion Inhibitors
Syn. Route 2
Route 1
the reaction of 5-methoxy-2-tetralone (i) with benzenethiosulfonic acid s-phenyl ester and sodium acetate in methanol gives 1,1-bis(phenylsulfanyl)-2-tetralone (ii), which is condensed with 2-(bromomethyl)acrylic acid tert-butyl ester (iii) by means of n-buli and diisopropylamine (dia) in thf to yield the acrylic acid derivative (iv). desulfurization of (iv) with al/hg in thf/water affords compound (v), which is treated with o-methylhydroxylamine and na2hpo4 in methanol, providing the methoxyimino compound (vi). the reduction of (vi) with zn/hoac provides the methoxyamino compound (vii). the cyclization of (vii) by means of potassium hydrogen phosphate gives 1,6-dimethoxy-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinoline-3-carboxylic acid tert-butyl ester as a diastereomeric mixture that is separated by chromatography to furnish the desired diastereomer (viii). hydrolysis of the tert-butoxy ester group of (viii) by means of tfa yields the carboxylic acid (ix), which is treated with diazomethane to afford the methyl ester (x). selective demethoxylation of (x) with zn/hoac provides the octahydrobenzoquinoline (xi).
List of intermediates No.
ethyl 3-[3-(2-[[(4-chlorophenyl)sulfonyl]amino]ethyl)-5-(4-fluorobenzyl)phenyl]propanoate (i)
4-acryloyl-10,10-dimethyl-3lambda~6~-thia-4-azatricyclo[5.2.1.0~1,5~]decane-3,3-dione (ii)
4-[(1r)-3-cyclohexen-1-ylcarbonyl]-10,10-dimethyl-3lambda~6~-thia-4-azatricyclo[5.2.1.0~1,5~]decane-3,3-dione (iii)
4-{[((1s,2e)-1-{(1s)-1-[2-((2r,3r,4e,7s,9s,10r,11s,13r)-3-allyl-2,10-bis{[tert-butyl(dimethyl)silyl]oxy}-9,11,14,14-tetramethoxy-5,7,13-trimethyl-4-tetradecenyl)-1,3-dithian-2-yl]ethyl}-3-{(1r,3r,4r)-3-methoxy-4-[(triisopropylsilyl)oxy]cyclohexyl}-2-methyl-2-propenyl)oxy]methyl}phenyl methyl ether (iv)
(1e,3s,4s,7r,8r,9e,12s,14s,15r,16s,18r)-8-allyl-7,15-bis{[tert-butyl(dimethyl)silyl]oxy}-14,16,19,19-tetramethoxy-3-[(4-methoxybenzyl)oxy]-1-{(1r,3r,4r)-3-methoxy-4-[(triisopropylsilyl)oxy]cyclohexyl}-2,4,10,12,18-pentamethyl-1,9-nonadecadien-5-one (v)
(1e,3s,4s,7r,8r,9e,12s,14s,15r,16s,18r)-8-allyl-7,15-bis{[tert-butyl(dimethyl)silyl]oxy}-3-hydroxy-14,16,19,19-tetramethoxy-1-{(1r,3r,4r)-3-methoxy-4-[(triisopropylsilyl)oxy]cyclohexyl}-2,4,10,12,18-pentamethyl-1,9-nonadecadien-5-one (vi)
(1e,3s,4r,5s,7r,8r,9e,12s,14s,15r,16s,18r)-8-allyl-7,15-bis{[tert-butyl(dimethyl)silyl]oxy}-14,16,19,19-tetramethoxy-1-{(1r,3r,4r)-3-methoxy-4-[(triisopropylsilyl)oxy]cyclohexyl}-2,4,10,12,18-pentamethyl-1,9-nonadecadiene-3,5-diol (vii)
(1e,3s,4s,5s,7r,8r,9e,12s,14s,15r,16s,18r)-8-allyl-7,15-bis{[tert-butyl(dimethyl)silyl]oxy}-14,16,19,19-tetramethoxy-1-{(1r,3r,4r)-3-methoxy-4-[(triisopropylsilyl)oxy]cyclohexyl}-2,4,10,12,18-pentamethyl-5-[(triisopropylsilyl)oxy]-1,9-nonadecadien-3-ol (viii)
(1s,2r,3s,5s,7e,9r,10r,12s,13s,14s,15e)-9-allyl-2,10-bis{[tert-butyl(dimethyl)silyl]oxy}-1-[(2r)-3,3-dimethoxy-2-methylpropyl]-3-methoxy-16-{(1r,3r,4r)-3-methoxy-4-[(triisopropylsilyl)oxy]cyclohexyl}-5,7,13,15-tetramethyl-14-[(triethylsilyl)oxy]-12-[(triisopropylsilyl)oxy]-7,15-hexadecadienyl methyl ether (ix)
(2r,4s,5r,6s,8s,10e,12r,13r,15s,16s,17s,18e)-12-allyl-5,13-bis{[tert-butyl(dimethyl)silyl]oxy}-4,6-dimethoxy-19-{(1r,3r,4r)-3-methoxy-4-[(triisopropylsilyl)oxy]cyclohexyl}-2,8,10,16,18-pentamethyl-17-[(triethylsilyl)oxy]-15-[(triisopropylsilyl)oxy]-10,18-nonadecadienal (x)
(2s)-1-{2-[(4-methoxybenzyl)oxy]acetyl}-2-piperidinecarboxylic acid (xi)
Reference 1:
    nordmann, r.; petcher, t.j.; octahydrobenzo[g]quinolines: potent dopamine agonists which show the relationship between ergolines and apomorphine. j med chem 1985, 28, 3, 367.
Reference 2:
    petcher, t.j.; nordmann, r. (novartis ag); novel pharmaceutically active 1,2,3,4,4a,5,10,10a-octahydrobenzo(g)quinoline derivs.. ep 0077754; es 8606281; es 8706120 .

Route 2
free nh group of (xi) is alkylated by reductocondensation with propionaldehyde (xii) and h2 over pd/c, giving the n-propyl derivative (xiii). the reaction of the ester group of (xiii) with hydrazine yields the corresponding hydrazide (xiv), which is submitted to degradation with nitrosyl chloride in thf to afford the amine (xv). the condensation of (xv) with n,n-diethylsulfamoyl chloride (xvi) by means of tea in chloroform gives the sulfamide (xvii), which is finally demethylated by a treatment with bbr3 in dichloromethane.
List of intermediates No.
(2r)-5-[[amino(imino)methyl]amino]-2-[(tert-butoxycarbonyl)amino]pentanoic acid (xii)
(2s)-1-{2-[(4-methoxybenzyl)oxy]acetyl}-2-piperidinecarboxylic acid (xi)
(2s)-1-{(4r,6s,7r,8s,10s,12e,14r,15r,17s,18s,19s,20e)-14-allyl-7,15-bis{[tert-butyl(dimethyl)silyl]oxy}-3-hydroxy-6,8-dimethoxy-2-[(4-methoxybenzyl)oxy]-21-{(1r,3r,4r)-3-methoxy-4-[(triisopropylsilyl)oxy]cyclohexyl}-4,10,12,18,20-pentamethyl-19-[(triethylsilyl)oxy]-17-[(triisopropylsilyl)oxy]-12,20-henicosadienoyl}-2-piperidinecarboxylic acid (xiii)
(2s)-1-{(4r,6s,7r,8s,10s,12e,14r,15r,17s,18s,19s,20e)-14-allyl-7,15-bis{[tert-butyl(dimethyl)silyl]oxy}-6,8-dimethoxy-2-[(4-methoxybenzyl)oxy]-21-{(1r,3r,4r)-3-methoxy-4-[(triisopropylsilyl)oxy]cyclohexyl}-4,10,12,18,20-pentamethyl-3-oxo-19-[(triethylsilyl)oxy]-17-[(triisopropylsilyl)oxy]-12,20-henicosadienoyl}-2-piperidinecarboxylic acid (xiv)
(2s)-1-{(4r,6s,7r,8s,10s,12e,14r,15r,17s,18s,19s,20e)-14-allyl-7,15-bis{[tert-butyl(dimethyl)silyl]oxy}-19-hydroxy-6,8-dimethoxy-2-[(4-methoxybenzyl)oxy]-21-{(1r,3r,4r)-3-methoxy-4-[(triisopropylsilyl)oxy]cyclohexyl}-4,10,12,18,20-pentamethyl-3-oxo-17-[(triisopropylsilyl)oxy]-12,20-henicosadienoyl}-2-piperidinecarboxylic acid (xv)
(3s,4s,5s,7r,8r,12s,14s,15r,16s,18r,26as)-8-allyl-7,15-bis{[tert-butyl(dimethyl)silyl]oxy}-14,16-dimethoxy-20-[(4-methoxybenzyl)oxy]-3-((e)-2-{(1r,3r,4r)-3-methoxy-4-[(triisopropylsilyl)oxy]cyclohexyl}-1-methylethenyl)-4,10,12,18-tetramethyl-5-[(triisopropylsilyl)oxy]-5,6,7,8,11,12,13,14,15,16,17,18,24,25,26,26a-hexadecahydro-3h-pyrido[2,1-c][1,4]oxazacyclotricosine-1,19,21(4h,20h,23h)-trione (xvi)
ethyl 1-benzyl-3-oxo-4-piperidinecarboxylate (xvii)
Reference 1:
    nordmann, r.; petcher, t.j.; octahydrobenzo[g]quinolines: potent dopamine agonists which show the relationship between ergolines and apomorphine. j med chem 1985, 28, 3, 367.
Reference 2:
    petcher, t.j.; nordmann, r. (novartis ag); novel pharmaceutically active 1,2,3,4,4a,5,10,10a-octahydrobenzo(g)quinoline derivs.. ep 0077754; es 8606281; es 8706120 .

来源:药化网

作者:药化小编

摘要:本文合成路线介绍的是药物中文名盐酸喹高莱;英文名Quinagolide hydrochloride;SDZ-205502;CV-205502;Norprolac;CAS[94424-50-7]

 
推荐VIP企业
无锡景耀生物科技有限公司
杭州卢普生物科技有限公司
宁波赛伦化工有限公司
苏州昊赛生物科技有限公司
北京嘉盛扬医药科技有限公司
上海泽涵生物医药科技有限公司
河北固安三利化工公司
郑州凯普瑞生物技术有限公司
上海药谷药业有限公司
兰州康寓信生物科技有限公司
湖北朗昕生化药业有限公司
武汉福鑫化工有限公司
嘉兴市英南化工有限公司
苏州迪飞医药科技有限公司
北京富安凯科技有限公司
上海盛中医药化工有限公司
连云港天和化学有限公司
南京晨瑞医药科技有限公司
南京苏如化工有限公司
常州瑞盛化工有限公司
热门文章
罗氏向 FDA 递交 Kadc
前列腺癌药物苯扎鲁胺达到 AR
欧盟批准武田霍奇金淋巴瘤药物
赛诺菲砍掉 38 个研发项目,
AZ 抗病毒药物 MEDI88
赛诺菲 Darzalex 竞争
默沙东向 FDA 提交两款抗菌
两降一涨!蓝丰/国发/新奥发布
华北地区醋酸价格
河南地区醋酸价格暂稳
华北地区丁二烯市场观望为主
华东地区BDO市场商谈整理
山东地区醋酸价格
陕西地区醋酸价格下调
江苏地区醋酸价格下调
PTA止跌在眼前
华东苯酐市场行情
华东地区丁二烯市场弱势盘整
浙江地区二氯甲烷价格暂稳
山东地区木薯酒精市场稳定
 友情链接
有机化学人才网  
首页 | 广告服务 | 建站服务 | 关于我们 | 联系我们 | 版权声明